CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

CDMO Subsection

Insights into the latest developments in CDMO services and manufacturing.

Continue reading

Injectables Subsection

Expert perspectives on the evolving needs of injectable therapies and packaging.

Continue reading

Nasal & Pulmonary Subsection

Exploring the latest developments in inhalation technologies, respiratory delivery and sustainability

Continue reading

Advertisement

CPHI Milan
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Lifecore Biomedical

Advertisement

Solstice
Volume 16 Issue 1

Generative AI and its Impact on Speed to Market for Pharmaceuticals

Did you know that it takes approximately seven years to develop and bring a new drug to market? However, this time can be significantly reduced by months or even yea...
Continue Reading →
Volume 15 Issue 4

The Trial Master File (TMF)

IPI speaks with Aaron Grant, VP of Solutions Consulting at Phlexglobal, (a PharmaLex Company)on how managing the TMF requires following best practice and taking adva...
Continue Reading →
Volume 15 Issue 2

The Future of AI in Biotechnology

On the Precipice of the New Technological Revolution The artificial intelligence revolution kicked into high gear seemingly overnight. Generative AI platforms lik...
Continue Reading →
Volume 14 issue 3

New Technology and Automation in Labs: Data Risks and Privacy Compliance Issues

Within healthcare and life sciences, data science plays a major role in research and innovation. Improvements in computational speeds, storage capacity and connectiv...
Continue Reading →
Volume 13 Issue 4

Cyber Risk: How Can Pharma Avoid Black Swan Events?

Rod Schregardus, pharma manufacturing lead at The Access Group, looks at the IT security threats facing pharma companies today, and the steps that can be taken to pr...
Continue Reading →
News

Short term reshoring the catalyst for longer term manufacturing innovations by 2030

China and the USA predicted to lead innovation by 2030 in an age of mass personalized therapeutics, cobots, AI, and automation delivering process improvements Ams...
Continue Reading →
News

Qventus receives $30M investment to bring AI to hospital workflows

The company said in a statement that it plans to use the new money to expand its platform, which uses artificial intelligence to improve hospital workflows. Hea...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Tjoapack
Aptar – 08/01/2026